Skip to Main content Skip to Navigation
Journal articles

Combinaison radiothérapie-immunothérapie en cancérologie génito-urinaire

Abstract : Immunotherapy occupies a growing place in urologic oncology, mainly for kidney and bladder cancers. On the basis of encouraging preclinical work, the combination of immunotherapy with radiotherapy aims to increase the tumor response, including in metastatic tumors, which raises many hopes, which this article reviews.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03540455
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, January 24, 2022 - 9:10:11 AM
Last modification on : Friday, September 2, 2022 - 3:24:42 PM
Long-term archiving on: : Monday, April 25, 2022 - 6:20:20 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

L. Ollivier, V. Guimas, E. Rio, L. Vaugier, I. Masson, et al.. Combinaison radiothérapie-immunothérapie en cancérologie génito-urinaire. Cancer/Radiothérapie, Elsevier Masson, 2021, 25 (6-7), pp.565-569. ⟨10.1016/j.canrad.2021.06.033⟩. ⟨inserm-03540455⟩

Share

Metrics

Record views

21